variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
APC-E1317Q,APC,"This rare variant has been hypothesized to increase risk of colon cancer. Later studies have contradicted this, finding no significant enrichment and concluding the variant does not increase risk.",Moderate,Uncertain,Pathogenic,0.0088,Cancer,Dominant,Heterozygous,11001924;14578138;17119068,rs1801166,3,chr5,112175240,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
MYO1A-G662E,MYO1A,"Although one report speculated that this variant may cause dominant, early-onset sensorineural hearing loss, the findings lacked statistical significance. Notably, this gene is not a clinically tested gene and another of the eight variants reported by these authors (S797F) has since been observed in a PGP participant with no symptoms of hearing loss.",Moderate,Uncertain,Pathogenic,0.026,Hearing and vision;Nervous system,Dominant,Heterozygous,12736868,rs33962952,5,chr12,57431402,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
LMNB2-R215Q,LMNB2,"Carriers of this variant have increased susceptibility to acquired partial lipodystrophy (""Barraquer-Simons syndrome"", loss of fat in the upper body) -- this syndrome is quite rare, however, so even for carriers the chances of developing the syndrome is very low (less than 1%).",Low,Likely,Pathogenic,0.011,Other,Dominant,Heterozygous,16826530,rs61726481,1,chr19,2435150,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Homozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
MBL2-G54D,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).",Low,Likely,Pathogenic,0.1,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs1800450,3,chr10,54531235,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Homozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Homozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
LRP5-A1330V,LRP5,"In a study of a UK population this variant was associated with a small increased risk of osteoporosis and osteoporotic bone fractures, with each copy of the variant presumed to have an additive effect. A study in Chinese young men failed to find an association with peak bone density.

 
",Low,Uncertain,Pathogenic,0.11,"Muscular, skeletal, and connective tissue",Complex/Other,Heterozygous,18455228;19148563;20953208,rs3736228,2,chr11,68201295,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
ABCG5-R50C,ABCG5,This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.,Low,Likely,Protective,0.068,Blood;Metabolism,Unknown,Heterozygous,19060911,rs6756629,1,chr2,44065090,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
LIG4-A3V,LIG4,One report has associated this with a decreased risk of multiple myeloma.,Low,Uncertain,Protective,0.036,Cancer,Dominant,Heterozygous,12471202,rs1805389,1,chr13,108863609,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
LPL-S474X,LPL,"This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.",Low,Uncertain,Protective,0.084,Metabolism,Unknown,Heterozygous,16574898;17463246;18193044;19802338;20429872;22042884,rs328,,chr8,19819724,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Heterozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
FBN2-S2580L,FBN2,"Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.078,Anatomical and congenital,Dominant,Heterozygous,9714438;10633129;16835936;17345643,rs2291628,,chr5,127609633,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
SDHD-H50R,SDHD,"Probably benign. Other mutations in this gene are implicated in causing hereditary paraganglioma or pheochromocytoma syndromes, but this variant is also found in unaffected controls and is considered a nonpathogenic polymorphism by most authors that have reported it.",Low,Uncertain,Benign,0.0066,Cancer,Unknown,Heterozygous,12111639;12386824;17639058;18678321,rs11214077,,chr11,111958677,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
CD19-R514H,CD19,Presumed benign.,Low,Uncertain,Benign,0.048,Other,Unknown,Heterozygous,,rs34763945,,chr16,28950051,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
COL5A2-P460S,COL5A2,"Tentatively benign. Although predicted to be damaging by Polyphen 2, this variant is seen in 2 out of 62 PGP & public genomes. OMIM lists other more disruptive variants (frameshift & nonsense) as reported to cause Ehlers-Danlos syndrome when homozygous.",Low,Uncertain,Benign,0.04,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,,rs35830636,,chr2,189932764,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
BRCA1-Q356R,BRCA1,"One common variant associated this variant with an increased risk of breast cancer, but a more recent, larger study found no association.",Low,Uncertain,Benign,0.046,Cancer,Unknown,Heterozygous,17341484;19661094,rs1799950,,chr17,41246481,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
FANCA-S1088F,FANCA,"Probably benign. One report hypothesized this variant causing Fanconi Anemia, but the allele frequency (3-7%) is high enough to contradict a highly penetrant pathogenic effect. Later authors have concluded this is a polymorphism, not pathogenic.",Low,Uncertain,Benign,0.058,Blood,Unknown,Heterozygous,10094191;14695169,rs17233497,0,chr16,89815152,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=4bd45df894939f90c832e8eb96f4b5048e97a310&access_token=e483b8d8a9086b4e22e045a230d97420
